Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1995-11-15
1999-03-30
Cook, Rebecca
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514177, 514178, 514179, A61K 3156
Patent
active
058889965
ABSTRACT:
The present invention relates to a method of inhibiting N-methyl-D-aspartate (NMDA) glutamate receptor-mediated ion channel activity (NMDA receptor activity), comprising contacting a neuronal cell (e.g., hippocampal neuron, spinal cord cell) with an effective amount (e.g., 1 to 500 .mu.M) of a derivative of pregnenolone sulfate. Derivatives of pregnenolone sulfate that inhibit NMDA receptor activity include pregnenolone sulfate in which the A ring includes at least one double bond or is fully unsaturated, the double bond at the C5-C6 position is reduced, the moiety at the C3, C10, C11 or C13 position is modified, alone or in combination. It further relates to pregnenolone sulfate derivatives which have modifications at other positions (e.g., C5, C7, C10, C16, C17, C18, C19, C20, C21), alone or in combination, and are inhibitors of NMDA recepteor activity. The pregnenolone sulfate derivatives differ from pregnenolone sulfate at least one position. The present invention also relates to a method of modulating or altering (e.g., potentiating; inhibiting) excitatory glutamate-mediated synaptic activity comprising contacting neurons with pregnenolone sulfate and derivatives of pregnenolone sulfate.
REFERENCES:
patent: 5212167 (1993-05-01), Farb
patent: 5366968 (1994-11-01), Farb
CA 122:23982 Irwinet et al, 1994.
CA 121:125584 Park-Chung et al, 1994.
CA 119:86563 Bowlby, 1993.
CA 119:20512 Farb, Mar. 18, 1993.
CA 117:185114 Malone, 1992.
Wong, M., and Moss, R.L., "Patch-Clamp Analysis of Direct Steroidal Modulation of Glutamate Receptor-Channels", Jour. of Neuroendocrinology, 6:347-355, (1994).
Bowlby, M.R., "Pregnenolone Sulfate Potentiation of N-Methyl-D-aspartate Receptor Channels in Hippocampal Neurons", Mol. Pharmacol., 43(5):813-819, (1993).
Irwin, R. P., et al., "Steroid Potentiation and Inhibition of N-Methyl-D-Aspartate Receptor-Mediated Intracellular Ca++ Responses: Structure-Activity Studies," J. Pharm. and Experimental Therapeutics, 271(2) :677-682 (1994).
Gyermek, L., et al., "Structure-Activity Relationship of Some Steroidal Hypnotic Agents," Steroids. CCX., 11:117-125 (1968).
Wu, F.-S., et al., "Pregnenolone Sulfate: A Positive Allosteric Modulator at the N-Methyl-D-aspartate Receptor," Molecular Pharmacology, 40:333-336 (1991).
Park-Chung, M., et al., "3.alpha.-Hydroxy-5.beta.-pregnan-20-one Sulfate: A Negative Modulator of the NMDA-Induced Current in Cultured Neurons," Molecular Pharmacology, 46:146-150 (1994).
Wieland, S., et al., "Anxiolytic Activity of the Progesterone Metabolite 5.alpha.-pregnan-3.alpha.-ol-20-one," Brain Research, 565:263-268 (1991).
Belelli, D., et al., "Anticonvulsant Profile of the Progesterone Metabolite 5.alpha.-pregnan-3.alpha.-ol-20-one," European Journal of Pharmacology, 166:325-329 (1989).
Lan, N. C., et al., "Neurocactive Steroid Actions at the GABA.sub.A Receptor," Hormones and Behavior, 28:537-544 (1994).
Cook Rebecca
Trustees of Boston University
LandOfFree
Inhibition of NMDA receptor activity and modulation of glutamate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of NMDA receptor activity and modulation of glutamate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of NMDA receptor activity and modulation of glutamate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1215207